Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 27;9(4):339.
doi: 10.3390/biomedicines9040339.

Novel Strategies for Treating Castration-Resistant Prostate Cancer

David Ka-Wai Leung  1 , Peter Ka-Fung Chiu  1 , Chi-Fai Ng  1 , Jeremy Yuen-Chun Teoh  1
Affiliations
Review

Novel Strategies for Treating Castration-Resistant Prostate Cancer

David Ka-Wai Leung et al. Biomedicines. .

Abstract

The development of castration resistance is an inevitable pathway for the vast majority of patients with advanced prostate cancer. Recently, there have been significant breakthroughs in the understanding and management options of castration-resistant prostate cancer. Three novel hormonal agents showed survival benefits in non-metastatic patients. As for metastatic disease, there was an even wider range of management options being investigated. This review summarized advances in the management of castration-resistant prostate cancer (CRPC) including emerging data on novel imaging techniques and treatment strategies.

Keywords: androgen deprivation therapy; castration resistance; prostate cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Ferlay J., Ervik M., Lam F., Colombet M., Mery L., Piñeros M., Znaor A., Soerjomataram I., Bray F. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer; Lyon, France: 2018.
    1. Feldman B.J., Feldman D. The development of androgen-independent prostate cancer. Nat. Rev. Cancer. 2001;1:34–45. doi: 10.1038/35094009. - DOI - PubMed
    1. Gelmann E.P. Molecular Biology of the Androgen Receptor. J. Clin. Oncol. 2002;20:3001–3015. doi: 10.1200/JCO.2002.10.018. - DOI - PubMed
    1. Hörnberg E., Ylitalo E.B., Crnalic S., Antti H., Stattin P., Widmark A., Bergh A., Wikström P. Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival. PLoS ONE. 2011;6:e19059. doi: 10.1371/journal.pone.0019059. - DOI - PMC - PubMed
    1. Cornford P., van den Bergh R.C., Briers E., Van den Broeck T., Cumberbatch M.G., De Santis M., Fanti S., Fossati N., Gandaglia G., Gillessen S. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastat-ic Prostate Cancer. Eur. Urol. 2020 doi: 10.1016/j.eururo.2020.09.046. - DOI - PubMed

LinkOut - more resources